Option chain shows key data for Cemtrex's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Cemtrex.

Cemtrex (NASDAQ:CETX) Stock, Option Chain

Cemtrex

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes the Security segment, Industrial Services segment and the Corporate segment. It generates maximum revenue from the Security segment. It geographically operates in USA, UK and India wherein maximum revenue is generated in USA.

Intuit,Sign,Is,Displayed,Near,Business,And,Financial,Software,Company

Earnings

News

Markets

Analyst Ratings

Trading Ideas

AMIX

APTO

CETX

ESTC

INTU

MATW

REPL

S&amp;P 500 Moves Higher; Intuit Shares Fall Following Q1 Results

oil-prices-5079975

Equities

Eurozone

Commodities

Intraday Update

ROST

Crude Oil Gains Over 1%; Ross Stores Earnings Top Views

Wall Street US stocks

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

DEVS

Dow Jumps 300 Points; Gap Posts Upbeat Earnings

Cemtrex Inc

DCGO

SHLT

DocGo Expands Collaboration With SHL Telemedicine, Integrating Smartheart For Advanced Mobile Health Services

WIIM

Jabil shares are trading higher after the company reported better-than-expected Q1 EPS and revenues.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Silence Therapeutics PLC &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>)</h3>
<ul>
<li>On Dec. 10, Chardan Capital analyst Keay Nakae maintained Silence Therapeutics with a Buy and maintained a $55 price target. The company's stock fell around 41% over the past month and has a <a href="https://www.benzinga.com/quote/SLN">52-week low of $5.81</a>.</li>
<li>RSI Value: 26.72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>SLN Price Action: Shares of Silence Therapeutics fell 3.4% to close at $6.51 on Tuesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"> latest SLN news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="901" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151.png" alt="" class="wp-image-697338" style="width:586px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151.png 901w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151-768x713.png 768w" sizes="(max-width: 901px) 100vw, 901px" /></a></figure>
<h3 class="wp-block-heading">ModivCare Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Nov. 6, ModivCare posted weaker-than-expected quarterly results. &#8220;This quarter has demonstrated positive momentum, reflected in both operational enhancements and strengthened relationships, even amid shifts in the broader healthcare market. We delivered solid third-quarter results, reporting $43 million of adjusted EBITDA and a 2% increase in consolidated revenue, driven primarily by 5% growth in our personal care services segment,&#8221; stated L. Heath Sampson, President and CEO. The company's stock fell around 26% over the past five days and <a href="https://www.benzinga.com/quote/MODV">has a 52-week low</a> of $11.00.</li>
<li>RSI Value: 28.52</li>
<li>MODV Price Action: Shares of ModivCare fell 11.4% to close at $14.10 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1">trend in MODV stock.</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="915" height="840" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152.png" alt="" class="wp-image-697341" style="width:603px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152.png 915w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152-768x705.png 768w" sizes="(max-width: 915px) 100vw, 915px" /></a></figure>
<h3 class="wp-block-heading">Olema Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>)</h3>
<ul>
<li>On Dec. 10, Olema Oncology presented updated clinical results for Palazestrant in combination with Ribociclib at the San Antonio Breast Cancer Symposium. The company's stock fell around 37% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/OLMA">low of $6.08</a>.</li>
<li>RSI Value: 23.69</li>
<li>OLMA Price Action: Shares of Olema Pharmaceuticals fell 4.7% to close at $6.14 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1">breakout in OLMA shares.</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="898" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153.png" alt="" class="wp-image-697342" style="width:639px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153.png 898w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153-768x720.png 768w" sizes="(max-width: 898px) 100vw, 898px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42531171/top-2-utilities-stocks-that-could-sink-your-portfolio-this-quarter">Top 2 Utilities Stocks That Could Sink Your Portfolio This Quarter</a></li>
</ul>

Long Ideas

Pre-Market Outlook

MODV

OLMA

Top 3 Health Care Stocks That May Explode In Q4

Earnings Beats

Jabil Q1 2025 Adj. EPS $2.00 Beats $1.88 Estimate, Sales $6.994B Beat $6.608B Estimate

Study Builds on Extensive Published Literature Highlighting the Benefits of the CyberKnife System in the Treatment of a Wide Range of Neurological Indications

ARAY

Accuray's CyberKnife System Offers Promising Outcomes For Brainstem Metastases, Highlighting Safety And Precision

Northland Capital Markets analyst Bobby Brooks maintains Excelerate Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EE#NYSE">EE</a>) with a Outperform and raises the price target from $29 to $37.

Price Target

Northland Capital Markets Maintains Outperform on Excelerate Energy, Raises Price Target to $37

Salesforce&nbsp;Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) targets employing 2,000 people in the form of sales reps, marketers, and customer service agents to sell <a target="_blank" href="https://www.benzinga.com/topic/ai" rel="noreferrer noopener">artificial intelligence</a> software to clients, CNBC <a target="_blank" href="https://www.cnbc.com/2024/12/17/salesforce-will-hire-2000-people-to-sell-ai-products-benioff-says.html" rel="noreferrer noopener">cited</a> CEO Marc Benioff at a company event in San Francisco on Tuesday.
In November, Benioff shared plans to employ 1,000 salespeople focusing on AI. Benioff told CNBC Salesforce already had 9,000 referrals for the 2,000 positions.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/24/12/42536593/verizon-teams-up-with-nvidia-to-power-ai-apps-over-private-5g-networks" rel="noreferrer noopener">Verizon Teams Up With Nvidia To Power AI Apps Over Private 5G Networks</a>
On Tuesday, Salesforce announced that a second generation&nbsp;of its Agentforce technology, capable of tackling questions in Salesforce's Slack communications app, will be <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42537776/introducing-agentforce-2-0-the-digital-labor-platform-for-building-a-limitless-workforce" rel="noreferrer noopener">available in February 2025</a>.
Salesforce has embedded experimental AI agents on its homepage to enhance user interaction. It manages 32,000 weekly queries through its chat-based help page, with only 5,000 requiring human escalation, down from 10,000.
Benioff highlighted these advancements as evidence of AI's growing role in improving customer support efficiency.
Benioff contrasted Salesforce's offerings with Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), noting the limited visibility of its Copilot-branded AI tools. Microsoft countered, stating that its AI solutions are driving measurable improvements, including a 9.4% boost in revenue per seller and an 11.5% reduction in case resolution time.
Salesforce's hiring spree comes nearly two years after the company laid off over 7,000 employees to adjust to economic conditions.
On Tuesday, Salesforce and Adecco Group boosted recruiting with Agentforce and Data Cloud for <a target="_blank" href="https://www.benzinga.com/news/contracts/24/12/42532242/salesforce-supercharges-adecco-vivint-with-ai-details" rel="noreferrer noopener">faster candidate matching</a>. Vivint, a provider of smart home and security solutions, tapped Agentforce to enhance its customer service&nbsp;teams with 24/7 autonomous agent support.
On TechCrunch's Equity podcast, Benioff <a target="_blank" href="https://techcrunch.com/2024/12/17/salesforce-plans-to-hire-2000-people-to-sell-its-ai-products/" rel="noreferrer noopener">predicted</a> that Salesforce will surpass a billion agents within the next 12 months. In October, Northland Capital Partners <a target="_blank" href="https://www.benzinga.com/top-stories/24/10/41145130/salesforces-genai-platform-agentforce-on-par-with-microsoft-analyst" rel="noreferrer noopener">stated that the</a> AgentForce platform now matches Microsoft's capabilities.
Salesforce&nbsp;stock surged over 37% year-to-date.
Salesforce reported <a target="_blank" href="https://www.benzinga.com/news/earnings/24/12/42302924/salesforce-q3-earnings-revenue-beat-eps-miss-free-cash-flow-up-30-ai-driving-groundbreaking-transformation-and-more" rel="noreferrer noopener">a third-quarter revenue</a> of $9.44 billion, up 8%, above the&nbsp;analyst consensus of $9.35 billion. The adjusted EPS of $2.41 missed the analyst consensus of $2.44.
Salesforce expects fourth-quarter revenue of $9.9 billion-$10.1 billion versus $10.04 billion analyst consensus. It anticipates fourth-quarter adjusted EPS of $2.57-$2.62 compared to consensus estimate of $2.61.&nbsp;
Investors can gain exposure to Salesforce through JPMorgan Equity Premium Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEPI#NYSE">JEPI</a>) and SPDR Series Trust SPDR Portfolio S&amp;P 500 Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPYG#NYSE">SPYG</a>).
Price Action: CRM stock traded higher by 0.71% to $353.47 premarket at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42536024/taiwan-eyes-amazons-kuiper-as-starlink-faces-hurdles" target="_blank" rel="noreferrer noopener">Amazon's Project Kuiper In Talks With Taiwan For Satellite Partnership</a></li>
</ul>
Photo via Shutterstock

Tech

Media

JEPI

MSFT

SPYG

Salesforce Doubles AI Hiring Goal, To Add 2K Sales Roles

NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) shares are experiencing a rise in premarket trading on Wednesday, as the company officially gears up for the launch of its new sub-brand, Firefly, which <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">is set to be unveiled this weekend.</a>
The Firefly brand, focused on premium smart electric vehicles for global urban consumers, made a significant step forward today with the launch of its official WeChat account, mini-program, and mobile app, <a target="_blank" href="https://cnevpost.com/2024/12/18/nio-warming-up-firefly-logo-app/" rel="noreferrer noopener">reports</a> CnEV Post.
The brand also revealed its logo for the first time.
Firefly draws inspiration from the firefly insect, known for its glowing, self-illuminating nature. The brand describes itself as small, agile, energetic, and dynamic, targeting a younger, urban audience.
In addition to Firefly&#8217;s preparations, NIO also shared six new images of its ET9 sedan on Weibo, featuring a sleek blue exterior and highlighting several design details, CnEV Post <a target="_blank" href="https://cnevpost.com/2024/12/18/nio-new-images-et9/" rel="noreferrer noopener">writes</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/previews/24/12/42549182/us-stocks-to-open-higher-as-rate-cut-expectations-surge-all-eyes-on-dow-jones-to-break-its-9-day-losing-streak" rel="noreferrer noopener">US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak</a>
This comes just before Nio Day 2024, which will take place this Saturday in Guangzhou, Guangdong province. The event will spotlight the Firefly sub-brand and its debut model, along with the official launch of the Nio ET9.
The Nio ET9, which was first revealed at Nio Day 2023, carries a pre-sale price of RMB 800,000, making it the most expensive vehicle in Nio&#8217;s lineup.
Deliveries are expected to begin in the first quarter of 2025, marking a key expansion of Nio&#8217;s product range to appeal to a broader market.
Price Action: NIO shares are trading higher by 1.10% to $4.59 premarket at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/24/12/42548385/fund-managers-increase-allocation-to-banking-and-insurance-stocks-in-december-here-are-the-best-performing-financial-stocks-in-2024" target="_blank" rel="noreferrer noopener">Fund Managers Increase Allocation To Banking And Insurance Stocks In December: Here Are The Best Performing Financial Stocks In 2024</a></li>
</ul>
Photo by Sundry Photography on Shutterstock.

Movers

Personal Finance

General

What's Going On With NIO Stock Today?

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) continues to trend downward, reflecting broader stagnation in <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42545419/bitcoin-ethereum-dogecoin-stay-muted-before-feds-interest-rate-decision-analyst-says-btc-in-parabolic-phase-reveals-its-duration">the cryptocurrency market</a>.   
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.3885</td>
<td>$57.2 billion</td>
<td>-4.1%</td>
<td>-3.6%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00002602</td>
<td>$15.3 billion</td>
<td>-4.7%</td>
<td>-5.9%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.00002179</td>
<td>$9.2 billion</td>
<td>-7.2%</td>
<td>-8.4%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader More Crypto Online notes that Dogecoin&#8217;s recent 4% drop means the price stuck in a consolidation phase. 
He <a href="https://x.com/Morecryptoonl/status/1869217158040879159">suggests</a> that holding above $0.365 could open the door for an upside breakout, but a drop below this level might direct attention to the $0.25–$0.337 support zone.
Crypto chart analyst Ali Martinez highlights negative market sentiment surrounding Dogecoin, attributing the current price stagnation to trader impatience during this extended consolidation period.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Market sentiment for <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> has turned negative. It seems as if traders are getting impatient during the ongoing price consolidation! <a href="https://t.co/yb29147Bvg">pic.twitter.com/yb29147Bvg</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1869119123919183935?ref_src=twsrc%5Etfw">December 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Kevin <a href="https://x.com/Kev_Capital_TA/status/1869159630045081778">adds</a> that Dogecoin continues to face resistance, failing to reclaim the Macro .786 Fib level for over a week and losing support at the Macro .5 Fib on the linear chart. 
He also points out bearish signals for Bitcoin, which faces rejection at its Macro 1.703 Fib level, alongside substantial downside liquidity risks.
Kevin believes the market&#8217;s short-term outlook leans bearish, given the Federal Reserve&#8217;s potential rate pause and the Bank of Japan&#8217;s anticipated rate hike.
Statistics: According to Coinglass, Dogecoin short liquidations have dropped to $629,800, the lowest level since Oct. 13.
Additionally, spot trading data shows continuous negative net flows since Dec. 12, with a net outflow of $34.3 million as of Dec.18.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42488734/dogecoin-price-stuck-around-40-cents-why-isnt-doge-moving">Dogecoin Price Stuck Around 40 Cents: Why Isn&#8217;t DOGE Moving?</a></li>
</ul>
Image: Shutterstock

$DOGE

$PEPE

$SHIB

Dogecoin Down Another 4% As Sentiment Sours: What Is Going On?

JP Morgan analyst Doug Anmuth maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Overweight and raises the price target from $212 to $232.

GOOGL

JP Morgan Maintains Overweight on Alphabet, Raises Price Target to $232

JMP Securities analyst Aaron Kimson initiates coverage on Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) with a Market Outperform rating and announces Price Target of $7.

Initiation

BLND

JMP Securities Initiates Coverage On Blend Labs with Market Outperform Rating, Announces Price Target of $7

Northland Capital Markets analyst Tim Savageaux reiterates Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) with a Outperform and raises the price target from $25 to $40.

Reiteration

AAOI

Northland Capital Markets Reiterates Outperform on Applied Optoelectronics, Raises Price Target to $40

Keybanc analyst Alex Markgraff upgrades BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) from Sector Weight to Overweight and announces $115 price target.

Upgrades

BILL

Keybanc Upgrades BILL Holdings to Overweight, Announces $115 Price Target

Northland Capital Markets analyst Michael Latimore initiates coverage on Rezolve AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLV#NASDAQ">RZLV</a>) with a Outperform rating and announces Price Target of $5.

RZLV

Northland Capital Markets Initiates Coverage On Rezolve AI with Outperform Rating, Announces Price Target of $5

Global fund managers are shrinking their cash holdings and investing heavily in U.S. stocks, pushing a key indicator to a level that Bank of America believes could signal an impending sell-off in global equities.
What Happened: The Bank of America&#8217;s survey of global fund managers has been showing a &#8220;super-bullish sentiment, with record low allocation to cash, record-high allocation to U.S. stocks and three-year high global risk appetite driven by &#8216;Trump 2.0&#8217; growth optimism and a compliant rate cut by Fed.&#8221;
Cash as a percentage of total assets under management dropped to 3.9% in December. The only time fund managers&#8217; cash allocations were near the current levels was during January to March in 2002 and in February 2011.
According to the BofA survey, a 3.9% cash allocation triggers a &#8220;sell signal,&#8221; as the allocation to the U.S. equities advanced to a record high of net 36% overweight.
See Also: <a href="https://www.benzinga.com/general/market-summary/24/12/42548385/fund-managers-increase-allocation-to-banking-and-insurance-stocks-in-december-here-are-the-best-performing-financial-stocks-in-2024">Fund Managers Increase Allocation To Banking And Insurance Stocks In December: Here Are The Best Performing Financial Stocks In 2024</a>
Why It Matters: This year, investors have flocked to U.S. stocks, anticipating that the America First policies proposed by President-elect Donald Trump will enhance domestic corporate earnings.
Morgan Stanley <a href="https://www.benzinga.com/markets/equities/24/12/42382786/morgan-stanley-narrows-down-winning-and-losing-bets-in-the-first-100-days-of-trump-administration">highlighted</a> certain headwinds to the positive developments expected by a majority of analysts and fund managers.
&#8220;Slower-than-expected deregulation and shallower tax cuts could impact the markets,&#8221; it said in a 2025 outlook.
&#8220;Investors should remain vigilant as tech valuations climb further, with an eye toward rebalancing opportunities early next year,&#8221; said Jeremy Siegel, a senior economist at WisdomTree and emeritus professor of finance at the University of Pennsylvania.
The BofA survey further notes that investors have been long &#8216;Magnificent Seven&#8217; stocks, seeing crowded trades for the 21st consecutive month.
Also, the allocation to emerging market equities fell by 23% points month-on-month in December, which was the lowest exposure to this sector since September 2024, before China announced its stimulus measures.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42546991/dows-rare-nine-day-decline-falls-behind-267-single-day-crashes-since-1900">Dow&#8217;s Rare Nine-Day Decline Falls Behind 267 Single-Day Crashes Since 1900: Is Tech Shift To Blame?</a></li>
</ul>
Photo courtesy: Unsplash

Analyst Color

Cash Holdings Of Asset Managers Lowest In 13 Years, Says BofA, Flagging 'Sell' Signal Amid 'Trump 2.0 Optimism'

CRGO

Freightos And Swiss WorldCargo Partner To Revolutionize Digital Air Cargo Booking Across Global Markets

Keybanc analyst Arvind Ramnani upgrades Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) from Sector Weight to Overweight and announces $126 price target.

QTWO

Keybanc Upgrades Q2 Holdings to Overweight, Announces $126 Price Target

Key preclinical milestone for novel, non-opioid extended-release pain therapeutic&nbsp;&nbsp;

SILO

Silo Pharma Launches Pharmacokinetic Study For SP-26, Targeting Non-Opioid Chronic Pain Treatment

AMST

Amesite Disclosed Nursemagic Enterprise Contract Wins In High Growth Companies With Hundreds Of Franchise Owners Across The Country

AGEN

Agenus Announced Five Presentations Featuring Botensilimab (Bot, An Fc-enhanced Anti-CTLA-4 Antibody) Plus Balstilimab (Bal, An Anti-PD-1 Antibody) At The Upcoming American Society Of Clinical Oncology Gastrointestinal Cancers Symposium

Cemtrex (CETX) announced that its subsidiary, Vicon Industries, unveiled NEXT, a next generation modular camera platform that transforms how securi...

Cemtrex's Vicon Industries unveils evolution of camera technology

Cemtrex (CETX) announced that its board of directors authorized the stockholders approved 1-for-35 reverse stock split of its common stock, par val...

Cemtrex announces 1-for-35 reverse stock split

These are the upcoming stock splits for the week of November 25 to November 29, based on&nbsp;TipRanks' Stock Splits Calendar. A&nbsp;stock split&n...

Upcoming Stock Splits This Week (November 25 to November 29) – Stay Invested

19:50 EST Cemtrex (CETX) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...

Cemtrex trading halted, news pending

Cemtrex (CETX) intends to acquire 100% ownership of the entity Vicon Industries, a New York based provider of mission critical security and video s...

Cemtrex to complete 100% acquisition of Vicon Industries

Cemtrex (CETX) announced that its subsidiary, Vicon, will integrate an Artificial Intelligence gun detection feature in its NEXT Cameras, which wil...

Cemtrex announces integration of gun detection feature into Vicon NEXT Cameras

Cemtrex (CETX) announced that its subsidiary, Vicon Industries, secured a partnership with Hailo, an AI chip manufacturer known for its high-perfor...

Cemtrex's Vicon announces new partnership with Hailo for NEXT

Cemtrex regains Nasdaq compliance

Cemtrex (CETX) has received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market notifying the Company that ...

Cemtrex regains compliance with Nasdaq listing requirement

Cemtrex's (CETX) Vicon Industries subsidiary has received a record breaking $10.4M order for a state government corrections facility in the mid-Atl...

Cemtrex's Vicon Industries secures $10.4M Valerus expansion order

APLM

GPUS

VCON

Contracts

Press Releases

Cemtrex's Advanced Industrial Services Secures $4.5 million Contract

Cemtrex's Advanced Industrial Services Awarded $4.7 Million Large-Scale Infrastructure Contract

Cemtrex's Vicon Industries Unveils the Next Evolution of Camera Technology with NEXT™ Modular Camera System

Cemtrex Announces 1-For-35 Reverse Stock Split

Cemtrex to Complete 100% Acquisition of Vicon Industries

Cemtrex Announces Integration of AI Armed Person Detection Feature in Vicon NEXT Cameras

Cemtrex's Advanced Industrial Services Awarded Two Contracts Totaling $6.7 Million from Derry Township Municipal Authority

Cemtrex's Vicon Announces New Partnership with AI Chipmaker Hailo for its New Modular Camera System, NEXT™

Cemtrex Regains Compliance with NASDAQ Listing Requirement

Cemtrex's Vicon Industries Secures $10.4 Million Valerus Expansion Order from State Government Corrections Customer

Comments

Cemtrex

Cemtrex (CETX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga